Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetCyclin-dependent kinase 9
LigandBDBM164883
Substrate/Competitorn/a
Meas. Tech.ChEMBL_2025113 (CHEMBL4678926)
EC50 220±n/a nM
Citation Barlaam, BCasella, RCidado, JCook, CDe Savi, CDishington, ADonald, CSDrew, LFerguson, ADFerguson, DGlossop, SGrebe, TGu, CHande, SHawkins, JHird, AWHolmes, JHorstick, JJiang, YLamb, MLMcGuire, TMMoore, JEO'Connell, NPike, APike, KGProia, TRoberts, BSan Martin, MSarkar, UShao, WStead, DSumner, NThakur, KVasbinder, MMVarnes, JGWang, JWang, LWu, DWu, LYang, BYao, T Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies. J Med Chem63:15564-15590 (2020) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
Cyclin-dependent kinase 9
Name:Cyclin-dependent kinase 9
Synonyms:C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:Enzyme Subunit
Mol. Mass.:42789.13
Organism:Homo sapiens (Human)
Description:n/a
Residue:372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP
ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK
FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS
QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL
ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP
AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNP
ATTNQTEFERVF
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM164883
n/a
NameBDBM164883
Synonyms:US9067888, 33
TypeSmall organic molecule
Emp. Form.C21H24FN3O3
Mol. Mass.385.432
SMILESCOc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@H](C2)NC(C)=O)c1 |r|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: